Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Mild to Moderate Alzheimer's Disease
NCT00976118Phase 2Completed
- Sponsor
- AB Science
- Start
- Feb 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of masitinib in Alzheimer's disease (AD), sponsored by AB Science. Started Feb 2006; status: completed.
02
Drugs
masitinib
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00976118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976118.